Jim O'Neill, Baron O'Neill of Gatley

Malaysian Genomics Inks Agreement in Expansion to Bangladesh

Retrieved on:

Monday, May 15, 2023

Defamation, ASC, Obesity, IAC, Arthritis, Genomics, Pathology, Spine, Jim O'Neill, Baron O'Neill of Gatley, SCA, CAR, BRICS, Jonathan Wells (intelligent design advocate), Tetraplegia, Tendinopathy, Rare-earth element, Drug

PETALING JAYA, Malaysia, May 15, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced a strategic cooperation agreement (SCA) with Toticell Limited for the distribution of the Group's products in Bangladesh.

Key Points:

PETALING JAYA, Malaysia, May 15, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced a strategic cooperation agreement (SCA) with Toticell Limited for the distribution of the Group's products in Bangladesh.
Mr. Sasha Nordin, CEO of Malaysian Genomics said, "Bangladesh represents a market with vast opportunities given its population of approximately 165 million people.
Malaysian Genomics is delighted to cooperate with Toticell to bring our products and services to Bangladesh."
Mr. Azri Azerai, Executive Director of Malaysian Genomics, said, "This collaboration with Toticell falls in line with Malaysian Genomics' strategic expansion plan which includes diversifying geographically and globally."